Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 1 , Pages 67-71, January 2009

Outcomes for intermediate risk prostate cancer: Are there advantages for surgery, external radiation, or brachytherapy?

  • Eric A. Klein, M.D.

      Affiliations

    • Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44195, USA
    • Taussig Cancer Center, Cleveland Clinic, Cleveland, OH 44195, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-216-444-5591; fax: +1-216-445-3532
    • ,
  • Jay Ciezki, M.D.

      Affiliations

    • Department of Radiation Oncology, Cleveland Clinic, Cleveland, OH 44195, USA
    • Taussig Cancer Center, Cleveland Clinic, Cleveland, OH 44195, USA
    • ,
  • Patrick A. Kupelian, M.D.

      Affiliations

    • M.D. Anderson Cancer Center Orlando, Orlando, FL 32806, USA
    • ,
  • Arul Mahadevan, M.D.

      Affiliations

    • Department of Radiation Oncology, Cleveland Clinic, Cleveland, OH 44195, USA
    • Taussig Cancer Center, Cleveland Clinic, Cleveland, OH 44195, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1078-1439(08)00075-6

doi:10.1016/j.urolonc.2008.04.001

Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 1 , Pages 67-71, January 2009

Article Tools

* Image Usage & Resolution